STOCK TITAN
  1. Home
  2. News
  3. SNWV

Sanuwave Health - SNWV STOCK NEWS

Welcome to our dedicated page for Sanuwave Health news (Ticker: SNWV), a resource for investors and traders seeking the latest updates and insights on Sanuwave Health stock.

Sanuwave Health, Inc. (SNWV) pioneers noninvasive regenerative solutions through its proprietary PACE™ technology, advancing wound care and tissue repair innovations. This dedicated news hub provides investors and medical professionals with essential updates on the company's progress in developing FDA-cleared medical devices.

Access authoritative information about SNWV's technological advancements, including clinical trial outcomes, regulatory milestones, and strategic partnerships. Our curated collection features:

• FDA clearance announcements for new medical devices
• Clinical study results demonstrating treatment efficacy
• Financial performance updates and corporate developments
• Technology licensing agreements and partnership news

Bookmark this page for reliable updates on Sanuwave Health's progress in revolutionizing noninvasive therapies for wound management, orthopedic conditions, and aesthetic procedures. Verify all investment decisions against official SEC filings and consult medical professionals for clinical guidance.

News

SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024)

Rhea-AI Summary
SANUWAVE Health, Inc. announces record-breaking preliminary revenues of $5.7 to $5.9 million for Q1 2024, marking a 51% to 56% increase over Q1 2023. UltraMist revenues surged by over 55%, contributing 95% to total revenues.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.5%
Tags
earnings
-
News

SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer

Rhea-AI Summary
SANUWAVE Health, Inc. announces the hiring of Peter Sorensen as CFO, bringing extensive finance, forecasting, and capital markets experience to drive growth in the wound care business.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.03%
Tags
management
-
News

SANUWAVE Announces Record Q4 and FY2023 Revenue

Rhea-AI Summary
SANUWAVE Health, Inc. reports record revenues for Q4 2023 and FY 2023, with significant growth in operating income. The company provides strong revenue growth guidance for Q1 2024 and FY 2024. UltraMIST® systems and consumables drive revenue growth, with a focus on profitable expansion. Adjusted EBITDA shows notable improvement, reflecting operational efficiencies. The company aims for rapid, profitable growth in the upcoming year, expecting substantial revenue increases.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1%
Tags
none
News

SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results

Rhea-AI Summary
SANUWAVE Health, Inc. to present Q4 and FY2023 financial results in a live conference call on March 22, 2024. The company, known for its FDA-approved wound care products, invites participants to join the call or access it online. Materials will be available on the company website, with a replay option until April 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.52%
Tags
conferences earnings
-
News

SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders

Rhea-AI Summary
SANUWAVE Health, Inc. announces stockholders' approval of business combination with SEP Acquisition Corp. at a special meeting. 70.5% of eligible shares voted or abstained, with 99.3% voting 'for' the proposal. CEO Morgan Frank expresses satisfaction with the outcome.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.75%
Tags
acquisition
-
News

SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA)

Rhea-AI Summary
SANUWAVE Health, Inc. (SNWV) is holding a special meeting of stockholders on February 21, 2024, to vote on the previously announced merger with SEP Acquisition Corp. Upon closing, the combined company is expected to trade on the Nasdaq Capital Market under the symbol 'SNWV'. Stockholders of record at the close of business on January 10, 2023, will be entitled to vote at the special meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.68%
Tags
acquisition
News

SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter and Fiscal Year 2023, Ended December 31, 2023

Rhea-AI Summary
SANUWAVE Health, Inc. (SNWV) announces record preliminary revenues of $6.6 million to $6.8 million for Q4 2023, representing a 20% to 24% increase over Q4 2022. FY 2023 revenue range was $20.0 million to $20.2 million, a 19% to 20% year-over-year increase. UltraMist product line drove Q4 2023 growth, accounting for approximately 95% of total revenues. CEO Morgan Frank expresses optimism for continued success in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.39%
Tags
earnings
-
News

SANUWAVE Announces Q3 2023 Financial Results

Rhea-AI Summary
SANUWAVE Health, Inc. (SNWV) announces 3rd quarter 2023 results, with a 19% increase in revenue to $5.0 million, driven by UltraMist® systems and consumables. Gross margin at 71%, operating loss down by $2.0 million. Net loss at $23.7 million due to non-cash losses on derivative liabilities. Recent highlights include a merger agreement with Nasdaq-listed company, hiring of industry veteran Andrew Walko, and focus on rapid, profitable growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.04%
Tags
earnings
-
News

SANUWAVE Will Host a Conference Call on November 10, 2023 at 8:00 AM (ET) to Present the Q3 2023 Financial Results

Rhea-AI Summary
SNWV - SANUWAVE Health, Inc. to Host Live Conference Call to Present Q3 2023 Financial Results. The leading provider of next-generation wound care products will present their Q3 2023 financial results in a live conference call on November 10, 2023, at 8:00AM (ET). Participants can access the call via telephone or an instant Call me™ link. A replay will be available through November 24, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.76%
Tags
conferences earnings
News

SANUWAVE Health Announces Preliminary Revenue Results for the Third Quarter Ended September 30, 2023

Rhea-AI Summary
SANUWAVE announces preliminary revenues of $4.7M to $4.9M for Q3 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
earnings
Stock SNWV logo
Sanuwave Health

OTC:SNWV

SNWV Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

SNWV Stock Data

256.28M
8.01M
3.86%
26.54%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
SUWANEE